Because of the beneficial effect of DAPK1 KO against Aβ42 species-induced cell death and tau phosphorylation, we further investigated the impact of a DAPK1-specific inhibitor on Aβ42-induced neuronal damage to confirm the efficacy of DAPK1 inhibition in AD. Here, MAPT is linked to Alzheimer disease.